P300-dependent STAT3 acetylation is necessary for angiotensin II-induced pro-fibrotic responses in renal tubular epithelial cells
Aim: To explore the role of signal transducer and activator of transcription 3 (STAT3) signaling pathway, especially STAT3 acetylation, in angiotensin II (Ang II)-induced pro-fibrotic responses in renal tubular epithelial cells. Methods: Rat renal tubular epithelial cell line (NRK-52E) was used. STA...
Saved in:
Published in | Acta pharmacologica Sinica Vol. 35; no. 9; pp. 1157 - 1166 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
01.09.2014
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Aim: To explore the role of signal transducer and activator of transcription 3 (STAT3) signaling pathway, especially STAT3 acetylation, in angiotensin II (Ang II)-induced pro-fibrotic responses in renal tubular epithelial cells. Methods: Rat renal tubular epithelial cell line (NRK-52E) was used. STAT3 acetylation, phosphorylation and Janus kinase 2 (Jak2) phosphorylation, as well as the expression of fibronectin, collagen IV, transforming growth factor-131 (TGF-β1) and p300 were examined using Western blotting. The level and localization of STAT3 phosphorylation on Tyr705 were detected with fluorescence immunocytochemistry. The cells were transfected with a plasmid vector carrying p300 gene or siRNA targeting p300 to regulate p300 expression. Results: Overexpression of p300 significantly increased STAT3 acetylation on Lys685, STAT3 phosphorylation on Tyr705, and the expression of TGF-β1, collagen IV and fibronectin in the cells. Treatment of the cells with Ang II (1 pmol/L) significantly increased STAT3 phosphorylation on Tyr705 through JAK2 activation, and dose-dependently increased the expression of fibronectin, collagen IV and TGF-β1. Pretreatment with curcumin, an inhibitor of JAK2 and p300, blocked Ang II-induced effects. Knockdown of p300 significantly decreased STAT3 acetylation on Lys685, and abolished Ang II-stimulated STAT3 phosphorylation on Tyr705, whereas pretreatment of the cells with C646, a selective inhibitor of p300, inhibited Ang II-induced STAT3 nuclear translocation and the expression of TGF- 131, collagen IV and fibronectin. Pretreatment of the cells with AG490, a JAK2 inhibitor, markedly inhibited Ang II-induced STAT3 phosphorylation on Tyr705 and fibronectin expression. Conclusion: P300-dependent STAT3 acetylation is necessary for Ang II-induced STAT3 phosphorylation and the consequent pro-fibrotic responses in renal tubular epithelial cells in vitro. |
---|---|
AbstractList | Aim: To explore the role of signal transducer and activator of transcription 3 (STAT3) signaling pathway, especially STAT3 acetylation, in angiotensin II (Ang II)-induced pro-fibrotic responses in renal tubular epithelial cells. Methods: Rat renal tubular epithelial cell line (NRK-52E) was used. STAT3 acetylation, phosphorylation and Janus kinase 2 (Jak2) phosphorylation, as well as the expression of fibronectin, collagen IV, transforming growth factor-131 (TGF-β1) and p300 were examined using Western blotting. The level and localization of STAT3 phosphorylation on Tyr705 were detected with fluorescence immunocytochemistry. The cells were transfected with a plasmid vector carrying p300 gene or siRNA targeting p300 to regulate p300 expression. Results: Overexpression of p300 significantly increased STAT3 acetylation on Lys685, STAT3 phosphorylation on Tyr705, and the expression of TGF-β1, collagen IV and fibronectin in the cells. Treatment of the cells with Ang II (1 pmol/L) significantly increased STAT3 phosphorylation on Tyr705 through JAK2 activation, and dose-dependently increased the expression of fibronectin, collagen IV and TGF-β1. Pretreatment with curcumin, an inhibitor of JAK2 and p300, blocked Ang II-induced effects. Knockdown of p300 significantly decreased STAT3 acetylation on Lys685, and abolished Ang II-stimulated STAT3 phosphorylation on Tyr705, whereas pretreatment of the cells with C646, a selective inhibitor of p300, inhibited Ang II-induced STAT3 nuclear translocation and the expression of TGF- 131, collagen IV and fibronectin. Pretreatment of the cells with AG490, a JAK2 inhibitor, markedly inhibited Ang II-induced STAT3 phosphorylation on Tyr705 and fibronectin expression. Conclusion: P300-dependent STAT3 acetylation is necessary for Ang II-induced STAT3 phosphorylation and the consequent pro-fibrotic responses in renal tubular epithelial cells in vitro. To explore the signal transducer and activator of transcription 3 (STAT3) signaling pathway, especially STAT3 acetylation, in angiotensin II (Ang II)-induced pro-fibrotic responses in renal tubular epithelial cells.AIMTo explore the signal transducer and activator of transcription 3 (STAT3) signaling pathway, especially STAT3 acetylation, in angiotensin II (Ang II)-induced pro-fibrotic responses in renal tubular epithelial cells.Rat renal tubular epithelial cell line (NRK-52E) was used. STAT3 acetylation and phosphorylation, as well as the expression of fibronectin, collagen IV and transforming growth factor-β1 (TGF-β1) were examined using Western blotting. The level and localization of STAT3 phosphorylation on Tyr705 were detected with fluorescence immunocytochemistry. The cells were transfected with a plasmid vector carrying p300 gene or siRNA targeting p300 to regulate p300 expression.METHODSRat renal tubular epithelial cell line (NRK-52E) was used. STAT3 acetylation and phosphorylation, as well as the expression of fibronectin, collagen IV and transforming growth factor-β1 (TGF-β1) were examined using Western blotting. The level and localization of STAT3 phosphorylation on Tyr705 were detected with fluorescence immunocytochemistry. The cells were transfected with a plasmid vector carrying p300 gene or siRNA targeting p300 to regulate p300 expression.Overexpression of p300 significantly increased STAT3 acetylation on Lys685, STAT3 phosphorylation on Tyr705, and the expression of TGF-β1, collagen IV and fibronectin in the cells. Treatment of the cells with Ang II (1 μmol/L) significantly increased STAT3 phosphorylation on Tyr705 through JAK2 activation, and dose-dependently increased the expression of fibronectin, collagen IV and TGF-β1. Pretreatment with curcumin, an inhibitor of JAK2 and p300, blocked Ang II-induced effects. Knockdown of p300 significantly decreased STAT3 acetylation on Lys685, and abolished Ang II-stimulated STAT3 phosphorylation on Tyr705, whereas pretreatment of the cells with C646, a selective inhibitor of p300, inhibited Ang II-induced STAT3 nuclear translocation and the expression of TGF-β1, collagen IV and fibronectin. Pretreatment of the cells with AG490, a JAK2 inhibitor, markedly inhibited Ang II-induced STAT3 phosphorylation on Tyr705 and fibronectin expression.RESULTSOverexpression of p300 significantly increased STAT3 acetylation on Lys685, STAT3 phosphorylation on Tyr705, and the expression of TGF-β1, collagen IV and fibronectin in the cells. Treatment of the cells with Ang II (1 μmol/L) significantly increased STAT3 phosphorylation on Tyr705 through JAK2 activation, and dose-dependently increased the expression of fibronectin, collagen IV and TGF-β1. Pretreatment with curcumin, an inhibitor of JAK2 and p300, blocked Ang II-induced effects. Knockdown of p300 significantly decreased STAT3 acetylation on Lys685, and abolished Ang II-stimulated STAT3 phosphorylation on Tyr705, whereas pretreatment of the cells with C646, a selective inhibitor of p300, inhibited Ang II-induced STAT3 nuclear translocation and the expression of TGF-β1, collagen IV and fibronectin. Pretreatment of the cells with AG490, a JAK2 inhibitor, markedly inhibited Ang II-induced STAT3 phosphorylation on Tyr705 and fibronectin expression.p300-dependent STAT3 acetylation is necessary for Ang II-induced STAT3 phosphorylation and the consequent pro-fibrotic responses in renal tubular epithelial cells in vitro.CONCLUSIONp300-dependent STAT3 acetylation is necessary for Ang II-induced STAT3 phosphorylation and the consequent pro-fibrotic responses in renal tubular epithelial cells in vitro. To explore the signal transducer and activator of transcription 3 (STAT3) signaling pathway, especially STAT3 acetylation, in angiotensin II (Ang II)-induced pro-fibrotic responses in renal tubular epithelial cells. Rat renal tubular epithelial cell line (NRK-52E) was used. STAT3 acetylation and phosphorylation, as well as the expression of fibronectin, collagen IV and transforming growth factor-β1 (TGF-β1) were examined using Western blotting. The level and localization of STAT3 phosphorylation on Tyr705 were detected with fluorescence immunocytochemistry. The cells were transfected with a plasmid vector carrying p300 gene or siRNA targeting p300 to regulate p300 expression. Overexpression of p300 significantly increased STAT3 acetylation on Lys685, STAT3 phosphorylation on Tyr705, and the expression of TGF-β1, collagen IV and fibronectin in the cells. Treatment of the cells with Ang II (1 μmol/L) significantly increased STAT3 phosphorylation on Tyr705 through JAK2 activation, and dose-dependently increased the expression of fibronectin, collagen IV and TGF-β1. Pretreatment with curcumin, an inhibitor of JAK2 and p300, blocked Ang II-induced effects. Knockdown of p300 significantly decreased STAT3 acetylation on Lys685, and abolished Ang II-stimulated STAT3 phosphorylation on Tyr705, whereas pretreatment of the cells with C646, a selective inhibitor of p300, inhibited Ang II-induced STAT3 nuclear translocation and the expression of TGF-β1, collagen IV and fibronectin. Pretreatment of the cells with AG490, a JAK2 inhibitor, markedly inhibited Ang II-induced STAT3 phosphorylation on Tyr705 and fibronectin expression. p300-dependent STAT3 acetylation is necessary for Ang II-induced STAT3 phosphorylation and the consequent pro-fibrotic responses in renal tubular epithelial cells in vitro. To explore the signal transducer and activator of transcription 3 (STAT3) signaling pathway, especially STAT3 acetylation, in angiotensin II (Ang II)-induced pro-fibrotic responses in renal tubular epithelial cells. Rat renal tubular epithelial cell line (NRK-52E) was used. STAT3 acetylation and phosphorylation, as well as the expression of fibronectin, collagen IV and transforming growth factor-[beta]1 (TGF-[beta]1) were examined using Western blotting. The level and localization of STAT3 phosphorylation on Tyr705 were detected with fluorescence immunocytochemistry. The cells were transfected with a plasmid vector carrying p300 gene or siRNA targeting p300 to regulate p300 expression. Overexpression of p300 significantly increased STAT3 acetylation on Lys685, STAT3 phosphorylation on Tyr705, and the expression of TGF-[beta]1, collagen IV and fibronectin in the cells. Treatment of the cells with Ang II (1 μmol/L) significantly increased STAT3 phosphorylation on Tyr705 through JAK2 activation, and dose-dependently increased the expression of fibronectin, collagen IV and TGF-[beta]1. Pretreatment with curcumin, an inhibitor of JAK2 and p300, blocked Ang II-induced effects. Knockdown of p300 significantly decreased STAT3 acetylation on Lys685, and abolished Ang II-stimulated STAT3 phosphorylation on Tyr705, whereas pretreatment of the cells with C646, a selective inhibitor of p300, inhibited Ang II-induced STAT3 nuclear translocation and the expression of TGF-[beta]1, collagen IV and fibronectin. Pretreatment of the cells with AG490, a JAK2 inhibitor, markedly inhibited Ang II-induced STAT3 phosphorylation on Tyr705 and fibronectin expression. p300-dependent STAT3 acetylation is necessary for Ang II-induced STAT3 phosphorylation and the consequent pro-fibrotic responses in renal tubular epithelial cells in vitro. Aim: To explore the signal transducer and activator of transcription 3 (STAT3) signaling pathway, especially STAT3 acetylation, in angiotensin II (Ang II)-induced pro-fibrotic responses in renal tubular epithelial cells. Methods: Rat renal tubular epithelial cell line (NRK-52E) was used. STAT3 acetylation and phosphorylation, as well as the expression of fibronectin, collagen IV and transforming growth factor-β1 (TGF-β1) were examined using Western blotting. The level and localization of STAT3 phosphorylation on Tyr705 were detected with fluorescence immunocytochemistry. The cells were transfected with a plasmid vector carrying p300 gene or siRNA targeting p300 to regulate p300 expression. Results: Overexpression of p300 significantly increased STAT3 acetylation on Lys685, STAT3 phosphorylation on Tyr705, and the expression of TGF-β1, collagen IV and fibronectin in the cells. Treatment of the cells with Ang II (1 μmol/L) significantly increased STAT3 phosphorylation on Tyr705 through JAK2 activation, and dose-dependently increased the expression of fibronectin, collagen IV and TGF-β1. Pretreatment with curcumin, an inhibitor of JAK2 and p300, blocked Ang II-induced effects. Knockdown of p300 significantly decreased STAT3 acetylation on Lys685, and abolished Ang II-stimulated STAT3 phosphorylation on Tyr705, whereas pretreatment of the cells with C646, a selective inhibitor of p300, inhibited Ang II-induced STAT3 nuclear translocation and the expression of TGF-β1, collagen IV and fibronectin. Pretreatment of the cells with AG490, a JAK2 inhibitor, markedly inhibited Ang II-induced STAT3 phosphorylation on Tyr705 and fibronectin expression. Conclusion: p300-dependent STAT3 acetylation is necessary for Ang II-induced STAT3 phosphorylation and the consequent pro-fibrotic responses in renal tubular epithelial cells in vitro . |
Author | Jun NI Yang SHEN Zhen WANG De-cui SHAO Jia LIU Ya-li KONG Lan-jun FU Li ZHOU Hong XUE Yu HUANG Wei ZHANG Chen YU Li-min LU |
AuthorAffiliation | Department of Physiology and Pathophysiology, Shanghai Medical College, Fudan University, Shanghai 200032, China Departmentof Nephrology, Tongii Hospital, Tongii University School of Medicine, Shanghai 200065, China; 3School of Biomedical Sciences andInstitute of Vascular Medicine, Chinese University of Hong Kong, Hong Kong, China |
Author_xml | – sequence: 1 givenname: Jun surname: Ni fullname: Ni, Jun organization: Department of Physiology and Pathophysiology, Shanghai Medical College, Fudan University – sequence: 2 givenname: Yang surname: Shen fullname: Shen, Yang organization: Department of Physiology and Pathophysiology, Shanghai Medical College, Fudan University – sequence: 3 givenname: Zhen surname: Wang fullname: Wang, Zhen organization: Department of Physiology and Pathophysiology, Shanghai Medical College, Fudan University – sequence: 4 givenname: De-cui surname: Shao fullname: Shao, De-cui organization: Department of Physiology and Pathophysiology, Shanghai Medical College, Fudan University – sequence: 5 givenname: Jia surname: Liu fullname: Liu, Jia organization: Department of Physiology and Pathophysiology, Shanghai Medical College, Fudan University – sequence: 6 givenname: Ya-li surname: Kong fullname: Kong, Ya-li organization: Department of Physiology and Pathophysiology, Shanghai Medical College, Fudan University – sequence: 7 givenname: Lan-jun surname: Fu fullname: Fu, Lan-jun organization: Department of Nephrology, Tongji Hospital, Tongji University School of Medicine – sequence: 8 givenname: Li surname: Zhou fullname: Zhou, Li organization: Department of Physiology and Pathophysiology, Shanghai Medical College, Fudan University – sequence: 9 givenname: Hong surname: Xue fullname: Xue, Hong organization: Department of Physiology and Pathophysiology, Shanghai Medical College, Fudan University – sequence: 10 givenname: Yu surname: Huang fullname: Huang, Yu organization: School of Biomedical Sciences and Institute of Vascular Medicine, Chinese University of Hong Kong – sequence: 11 givenname: Wei surname: Zhang fullname: Zhang, Wei organization: Department of Physiology and Pathophysiology, Shanghai Medical College, Fudan University – sequence: 12 givenname: Chen surname: Yu fullname: Yu, Chen email: yuchen2001@hotmail.com organization: Department of Nephrology, Tongji Hospital, Tongji University School of Medicine – sequence: 13 givenname: Li-min surname: Lu fullname: Lu, Li-min email: lulimin@shmu.edu.cn organization: Department of Physiology and Pathophysiology, Shanghai Medical College, Fudan University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25088002$$D View this record in MEDLINE/PubMed |
BookMark | eNptkttrFDEUxoNU7EWffJegL4LOmkwuk3kplOJloaDg-hyymTO7KbPJNMkIffQ_N-NuSy19Ssj5nY_vyzmn6MgHDwi9pmRBCVOfzJgWNaF8IfgzdEIbLqqmFvyo3GVDK04UO0anKV0TwmpG2xfouBZEKULqE_TnByOk6mAE34HP-OfqYsWwsZBvB5Nd8Ngl7MFCSibe4j5EbPzGhQw-OY-Xy8r5brLQ4TGGqnfrGLKzOEIag0-QcIEieDPgPK2nwUQMo8tbGFx5sjAM6SV63pshwavDeYZ-ffm8uvxWXX3_ury8uKqsYG2uGCXlbEVjTK-sEVT0khnoWwOGsxKsU0y2zEgrpeysKtWe9rVRlNK2big7Q-d73XFa76CzJW00gx6j25VkOhin_694t9Wb8FtzKoSomyLw_iAQw80EKeudS3ME4yFMSVMhCWmFakRB3z1Cr8MUyy_MlGgJUYLNjt48dHRv5W46BaB7wMaQUoReW5f_TaUYdIOmRM8boMsG6HkDtOCl58OjnjvZp-mPezoVym8gPjD6JP72IL4NfnNTOu7VpWSCKyIp-wt8fs0Y |
CitedBy_id | crossref_primary_10_1016_j_cellsig_2022_110407 crossref_primary_10_1016_j_ijbiomac_2023_128567 crossref_primary_10_1002_iub_2574 crossref_primary_10_1093_nar_gkw826 crossref_primary_10_18632_oncotarget_26110 crossref_primary_10_1016_j_taap_2015_11_011 crossref_primary_10_1155_2017_2418671 crossref_primary_10_1186_s11658_024_00590_w crossref_primary_10_3389_fphar_2016_00126 crossref_primary_10_1016_j_kint_2017_03_006 crossref_primary_10_1038_s41698_021_00158_3 crossref_primary_10_1186_s12964_022_00870_y crossref_primary_10_1016_j_ijcard_2016_11_204 crossref_primary_10_1016_j_apsb_2025_02_007 crossref_primary_10_1016_j_jnutbio_2022_109031 crossref_primary_10_1038_s41392_023_01379_7 crossref_primary_10_1038_aps_2016_12 crossref_primary_10_1155_2021_6673343 crossref_primary_10_1038_srep20481 crossref_primary_10_1111_ajt_14221 crossref_primary_10_1016_j_biopha_2023_115166 crossref_primary_10_1016_j_bbamcr_2015_10_019 crossref_primary_10_3389_fphar_2022_760308 crossref_primary_10_4049_jimmunol_2001178 crossref_primary_10_1111_jcmm_17447 crossref_primary_10_1161_ATVBAHA_118_311276 crossref_primary_10_4049_immunohorizons_2100112 crossref_primary_10_1038_s42003_024_07134_0 crossref_primary_10_1016_j_phymed_2018_09_182 crossref_primary_10_1111_bph_14686 crossref_primary_10_1038_s41419_019_1589_y crossref_primary_10_3390_biomedicines12092102 |
Cites_doi | 10.1038/aps.2012.18 10.1152/ajprenal.00620.2012 10.1126/science.1105166 10.1152/ajprenal.00477.2011 10.1038/aps.2012.164 10.1038/aps.2014.42 10.1152/ajpendo.00432.2009 10.1046/j.1523-1755.2003.00133.x 10.1038/379645a0 10.1152/ajprenal.00326.2007 10.1074/jbc.M413930200 10.1111/j.1440-1797.2007.00881.x 10.1016/j.regpep.2009.09.001 10.1681/ASN.2011050493 10.1161/HYPERTENSIONAHA.110.164244 10.1016/j.alcohol.2008.02.004 10.1038/emboj.2009.210 10.1016/0092-8674(95)90311-9 10.1096/fj.10-172288 10.1038/sj.ki.5000054 10.1016/j.chembiol.2010.03.006 10.1016/j.mce.2009.10.008 10.4049/jimmunol.171.11.6072 10.2337/db11-0478 10.1186/1476-4598-13-66 10.1007/s10549-012-2069-6 10.1053/j.gastro.2005.07.055 10.1046/j.1365-2141.2000.02127.x 10.1046/j.1523-1755.2002.00311.x 10.1172/JCI0215644 10.1038/aps.2014.16 10.2337/db06-0519 10.1161/01.RES.82.2.244 10.1152/ajprenal.00650.2012 10.1152/ajprenal.00282.2009 10.1038/jid.2013.187 10.1097/01.ASN.0000106015.29070.E7 10.1210/mend.16.4.0811 10.1593/neo.13478 10.1002/jcb.23135 10.1172/JCI0215518 10.1371/journal.pone.0055481 10.1186/1476-9255-7-19 10.1038/sj.onc.1203476 10.1093/ndt/gfs260 10.1253/circj.CJ-10-1072 10.1038/aps.2012.40 10.1007/s00395-012-0263-7 10.1002/ar.22820 10.1046/j.1523-1755.2002.00430.x 10.1016/j.urology.2009.02.059 10.2174/157340606776056133 10.1038/nm888 10.1038/cddis.2013.159 10.1074/jbc.M805941200 10.1053/j.ackd.2005.07.011 10.1016/j.nut.2008.12.007 |
ContentType | Journal Article |
Copyright | CPS and SIMM 2014 Copyright Nature Publishing Group Sep 2014 Copyright © 2014 CPS and SIMM 2014 CPS and SIMM |
Copyright_xml | – notice: CPS and SIMM 2014 – notice: Copyright Nature Publishing Group Sep 2014 – notice: Copyright © 2014 CPS and SIMM 2014 CPS and SIMM |
DBID | 2RA 92L CQIGP W91 ~WA AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QP 7QR 7T5 7TK 7TO 7U9 7X7 7XB 88E 8FD 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7N M7P P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM |
DOI | 10.1038/aps.2014.54 |
DatabaseName | 维普期刊资源整合服务平台 中文科技期刊数据库-CALIS站点 中文科技期刊数据库-7.0平台 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Immunology Abstracts Neurosciences Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student Oncogenes and Growth Factors Abstracts Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Algology Mycology and Protozoology Abstracts (Microbiology C) Health & Medical Research Collection Biological Science Collection AIDS and Cancer Research Abstracts Chemoreception Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE ProQuest Central Student |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
DocumentTitleAlternate | P300-dependent STAT3 acetylation is necessary for angiotensin II-induced pro-fibrotic responses in renal tubular epithelial cells |
EISSN | 1745-7254 |
EndPage | 1166 |
ExternalDocumentID | PMC4155527 3420527751 25088002 10_1038_aps_2014_54 663548061 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -05 -0E -Q- -S~ .3N 0R~ 188 1OC 23M 2RA 2WC 31~ 36B 3V. 4.4 406 53G 5GY 5VR 5VS 6J9 70F 7X7 8-1 88E 8FI 8FJ 8R4 8R5 8RM 92L 92M 9D9 9DE A8Z AADWK AANZL AATNV AAWBL AAYFA AAYJO AAZLF ABAWZ ABGIJ ABKZE ABUWG ACAOD ACBMV ACBRV ACBYP ACGFO ACGFS ACIGE ACIWK ACKTT ACPRK ACRQY ACTTH ACVWB ACXQS ACZOJ ADBBV ADFRT ADHDB ADMDM ADQMX ADRAZ ADYYL AEDAW AEFTE AEJRE AENEX AESKC AEVLU AEXYK AFBPY AFKRA AFNRJ AFRAH AFSHS AFUIB AFZJQ AGAYW AGEZK AGGBP AGHAI AHMBA AHSBF AILAN AJAOE AJCLW AJDOV AJRNO ALFFA ALMA_UNASSIGNED_HOLDINGS AMRJV AMYLF AOIJS AXYYD BAWUL BBNVY BENPR BFHJK BHPHI BKKNO BPHCQ BVXVI C1A CAG CAJEE CAJUS CCEZO CCPQU CHBEP CIEJG CO8 COF CQIGP CS3 CW9 DIK DNIVK DPUIP E3Z EBLON EBS EE. EIOEI EJD EMB EMOBN ESTFP F5P FA0 FDQFY FERAY FIZPM FSGXE FYUFA GX1 HCIFZ HH5 HMCUK HYE HZI HZ~ IWAJR JSO JUIAU JZLTJ K97 KQ8 LH4 LW6 M1P M48 M7P MK0 NQJWS NXXTH NYICJ O9- OK1 OVD P2P P6G PQQKQ PROAC PSQYO Q-- Q-4 Q2X R-E RNT RNTTT RPM RT5 S.. SNX SNYQT SOHCF SRMVM SV3 SWTZT T8U TAOOD TBHMF TDRGL TEORI TR2 TSG U1F U1G U5E U5O UKHRP UZ5 W91 ~88 ~NG ~WA -SE AACDK AASML AAXDM ABAKF ABZZP ACMJI AEFQL AEMSY AFBBN AGQEE AIGIU ALIPV FIGPU LGEZI LOTEE NADUK ROL AAYXX ABBRH ABDBE ABFSG ACMFV ACSTC AEZWR AFDZB AFHIU AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT SOJ CGR CUY CVF ECM EIF NPM 7QP 7QR 7T5 7TK 7TO 7U9 7XB 8FD 8FE 8FH 8FK ABRTQ AZQEC DWQXO FR3 GNUQQ H94 K9. LK8 M7N P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c539t-310539957aaf8ca515f63aef9aea43323d83693a6c666dc8f63f1f2a811192713 |
IEDL.DBID | M48 |
ISSN | 1671-4083 1745-7254 |
IngestDate | Thu Aug 21 13:34:51 EDT 2025 Fri Jul 11 00:30:25 EDT 2025 Fri Jul 25 08:53:21 EDT 2025 Thu Apr 03 07:02:39 EDT 2025 Thu Apr 24 23:03:19 EDT 2025 Tue Jul 01 02:04:12 EDT 2025 Fri Feb 21 02:40:28 EST 2025 Wed Feb 14 10:36:00 EST 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | p300 AG490 angiotensin II STAT3 C646 renal fibrosis renal tubular epithelial cells JAK2 extracellular matrix curcumin |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c539t-310539957aaf8ca515f63aef9aea43323d83693a6c666dc8f63f1f2a811192713 |
Notes | renal fibrosis; angiotensin II; renal tubular epithelial cells; STAT3; JAK2; extracellular matrix; p300; curcumin; C646; AG490 Aim: To explore the role of signal transducer and activator of transcription 3 (STAT3) signaling pathway, especially STAT3 acetylation, in angiotensin II (Ang II)-induced pro-fibrotic responses in renal tubular epithelial cells. Methods: Rat renal tubular epithelial cell line (NRK-52E) was used. STAT3 acetylation, phosphorylation and Janus kinase 2 (Jak2) phosphorylation, as well as the expression of fibronectin, collagen IV, transforming growth factor-131 (TGF-β1) and p300 were examined using Western blotting. The level and localization of STAT3 phosphorylation on Tyr705 were detected with fluorescence immunocytochemistry. The cells were transfected with a plasmid vector carrying p300 gene or siRNA targeting p300 to regulate p300 expression. Results: Overexpression of p300 significantly increased STAT3 acetylation on Lys685, STAT3 phosphorylation on Tyr705, and the expression of TGF-β1, collagen IV and fibronectin in the cells. Treatment of the cells with Ang II (1 pmol/L) significantly increased STAT3 phosphorylation on Tyr705 through JAK2 activation, and dose-dependently increased the expression of fibronectin, collagen IV and TGF-β1. Pretreatment with curcumin, an inhibitor of JAK2 and p300, blocked Ang II-induced effects. Knockdown of p300 significantly decreased STAT3 acetylation on Lys685, and abolished Ang II-stimulated STAT3 phosphorylation on Tyr705, whereas pretreatment of the cells with C646, a selective inhibitor of p300, inhibited Ang II-induced STAT3 nuclear translocation and the expression of TGF- 131, collagen IV and fibronectin. Pretreatment of the cells with AG490, a JAK2 inhibitor, markedly inhibited Ang II-induced STAT3 phosphorylation on Tyr705 and fibronectin expression. Conclusion: P300-dependent STAT3 acetylation is necessary for Ang II-induced STAT3 phosphorylation and the consequent pro-fibrotic responses in renal tubular epithelial cells in vitro. 31-1347/R ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://www.nature.com/articles/aps201454.pdf |
PMID | 25088002 |
PQID | 1559008531 |
PQPubID | 28815 |
PageCount | 10 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4155527 proquest_miscellaneous_1560095875 proquest_journals_1559008531 pubmed_primary_25088002 crossref_citationtrail_10_1038_aps_2014_54 crossref_primary_10_1038_aps_2014_54 springer_journals_10_1038_aps_2014_54 chongqing_primary_663548061 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014-09-01 |
PublicationDateYYYYMMDD | 2014-09-01 |
PublicationDate_xml | – month: 09 year: 2014 text: 2014-09-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: United States – name: Shanghai |
PublicationTitle | Acta pharmacologica Sinica |
PublicationTitleAbbrev | Acta Pharmacol Sin |
PublicationTitleAlternate | Acta Pharmacologica Sinica |
PublicationYear | 2014 |
Publisher | Nature Publishing Group UK Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
References | Schindler (CR15) 2002; 109 Chiu, Khan, Farhangkhoee, Chakrabarti (CR34) 2009; 25 Jain, Wei, Mitrani, Bishopric (CR39) 2012; 135 Liu (CR2) 2006; 69 Amiri, Shaw, Wang, Tang, Waller, Eaton (CR19) 2002; 61 Yan, Eller, Elm, Larocca, Ryu, Panova (CR52) 2013; 133 Meydan, Grunberger, Dadi, Shahar, Arpaia, Lapidot (CR53) 1996; 379 Wen, Zhong, Darnell (CR26) 1995; 82 Gao, Lin, Ning, Gao, Yao, Zhou (CR51) 2013; 8 Kodama, Fukuda, Pan, Makino, Sano, Takahashi (CR16) 1998; 82 Kandalam, Clark (CR18) 2010; 159 Bromberg, Darnell (CR21) 2000; 19 Kaur, Chen, Xin, Chiu, Khan, Chakrabarti (CR33) 2006; 55 Li, Li, Guo, Chu, Gao, Zhu (CR11) 2013; 34 Chen, Feng, George, Chakrabarti, Chen, Chakrabarti (CR35) 2010; 298 Qian, Wang, Yao, Wang, Xue, Liu (CR55) 2013; 296 Eddy (CR1) 2005; 12 Yuan Z, Guan Y, Chatterjee, Chin (CR28) 2005; 307 Scuto, Kirschbaum, Buettner, Kujawski, Cermak, Atadja (CR40) 2013; 4 Ivanova, Butt, Matsell (CR8) 2008; 294 Wang, Yang, Yang, Cang, Huang, Li (CR31) 2012; 33 He, Zhang, Shao, Xue, Zhou, Wang (CR44) 2010; 315 Ranganathan, Jayakumar, Ramesh (CR9) 2013; 304 Wang, Cherukuri, Luo (CR27) 2005; 280 Zhong, Guo, Chen, Wang, Schuster, Loibner (CR10) 2011; 57 Liu (CR5) 2004; 15 Guo, Li, Wang, Lei L, Yu, Chen (CR56) 2014; 35 Zeisberg, Hanai, Sugimoto, Mammoto, Charytan, Strutz (CR7) 2003; 9 Hendrayani, Al-Khalaf, Aboussekhra (CR49) 2013; 15 Grande, Perez-Barriocanal, Lopez-Novoa (CR13) 2010; 7 Marcu, Jung, Lee, Chung, Lee, Trepel (CR45) 2006; 2 Bowers, Yan, Mukherjee, Orry, Wang, Holbert (CR50) 2010; 17 De Vos, Jourdan, Tarte, Jasmin, Klein (CR54) 2000; 109 Uchida, Miyajima, Kikuchi, Kozakai, Kosaka, Ieda (CR12) 2009; 74 Iwano, Plieth, Danoff, Xue, Okada, Neilson (CR4) 2002; 110 Sethi, Chatterjee, Rajendran, Li, Shanmugam, Wong K (CR41) 2014; 13 Hou, Ray, Lee, Brasier (CR32) 2008; 283 Chen, Wang, Zhou, Wang, Feng (CR20) 2003; 64 Ni, Shen, Wang, Shao, Liu, Fu (CR43) 2014; 35 Sestito, Madonna, Scarponi, Cianfarani, Failla, Cavani (CR38) 2011; 25 Tang, Lai (CR14) 2012; 27 Ray, Sherman, Lu, Brasier (CR29) 2002; 16 Hua, Feng, Rezonzew, Chumley, Jaimes (CR37) 2012; 302 Kuratsune, Masaki, Hirai, Kiribayashi, Yokoyama, Arakawa (CR23) 2007; 12 Liu, Hu, Long, Qiu, Mei, Hu (CR22) 2012; 33 Kim, Park, Joe, Jou (CR47) 2003; 171 Liu, Guo, Pang, Tolbert, Ponnusamy, Gong (CR25) 2012; 23 Feng, Chen, Mcarthur, Wu, Sen, Ding (CR36) 2011; 60 Duan, Yang, Yan, Yu, Liu, Zhou (CR48) 2012; 107 Weng, Aroor, Shukla (CR17) 2008; 42 Pang, Ma, Liu, Ponnusamy, Zhao, Yan (CR42) 2011; 112 Sunagawa, Morimoto, Wada, Takaya, Katanasaka, Kawamura (CR46) 2011; 75 Matsui, Rhee, Hile, Zhang, Meldrum (CR3) 2013; 305 Huang, Han, Wang, Sun, Yan, Yeh (CR30) 2009; 28 Pang, Kothapally, Mao, Tolbert, Ponnusamy, Chin (CR24) 2009; 297 Rastaldi, Ferrario, Giardino, Dell'Antonio, Grillo, Grillo (CR6) 2002; 62 Ray, Boldogh, Brasier (CR57) 2005; 129 T Hou (BFaps201454_CR32) 2008; 283 R Wang (BFaps201454_CR27) 2005; 280 R Sestito (BFaps201454_CR38) 2011; 25 SC Tang (BFaps201454_CR14) 2012; 27 Y Liu (BFaps201454_CR2) 2006; 69 DB Liu (BFaps201454_CR22) 2012; 33 G Sethi (BFaps201454_CR41) 2014; 13 Y Sunagawa (BFaps201454_CR46) 2011; 75 YI Weng (BFaps201454_CR17) 2008; 42 Y Uchida (BFaps201454_CR12) 2009; 74 S Ray (BFaps201454_CR29) 2002; 16 F Matsui (BFaps201454_CR3) 2013; 305 N Liu (BFaps201454_CR25) 2012; 23 S Ray (BFaps201454_CR57) 2005; 129 MP Rastaldi (BFaps201454_CR6) 2002; 62 M Zeisberg (BFaps201454_CR7) 2003; 9 Y Wang (BFaps201454_CR31) 2012; 33 F Amiri (BFaps201454_CR19) 2002; 61 M Pang (BFaps201454_CR24) 2009; 297 L Ivanova (BFaps201454_CR8) 2008; 294 CW Schindler (BFaps201454_CR15) 2002; 109 S Jain (BFaps201454_CR39) 2012; 135 Y Liu (BFaps201454_CR5) 2004; 15 M Iwano (BFaps201454_CR4) 2002; 110 P Hua (BFaps201454_CR37) 2012; 302 J Ni (BFaps201454_CR43) 2014; 35 S Chen (BFaps201454_CR35) 2010; 298 U Kandalam (BFaps201454_CR18) 2010; 159 J Bromberg (BFaps201454_CR21) 2000; 19 J Zhong (BFaps201454_CR10) 2011; 57 MG Marcu (BFaps201454_CR45) 2006; 2 EM Bowers (BFaps201454_CR50) 2010; 17 MT Grande (BFaps201454_CR13) 2010; 7 N Meydan (BFaps201454_CR53) 1996; 379 XN Gao (BFaps201454_CR51) 2013; 8 YQ Li (BFaps201454_CR11) 2013; 34 C Huang (BFaps201454_CR30) 2009; 28 AA Eddy (BFaps201454_CR1) 2005; 12 C Qian (BFaps201454_CR55) 2013; 296 B Feng (BFaps201454_CR36) 2011; 60 HY Kim (BFaps201454_CR47) 2003; 171 J De Vos (BFaps201454_CR54) 2000; 109 W Duan (BFaps201454_CR48) 2012; 107 D Guo (BFaps201454_CR56) 2014; 35 L Yuan Z (BFaps201454_CR28) 2005; 307 M He (BFaps201454_CR44) 2010; 315 G Yan (BFaps201454_CR52) 2013; 133 A Scuto (BFaps201454_CR40) 2013; 4 H Kodama (BFaps201454_CR16) 1998; 82 P Ranganathan (BFaps201454_CR9) 2013; 304 SF Hendrayani (BFaps201454_CR49) 2013; 15 J Chiu (BFaps201454_CR34) 2009; 25 M Kuratsune (BFaps201454_CR23) 2007; 12 X Chen (BFaps201454_CR20) 2003; 64 H Kaur (BFaps201454_CR33) 2006; 55 M Pang (BFaps201454_CR42) 2011; 112 Z Wen (BFaps201454_CR26) 1995; 82 23698071 - J Invest Dermatol. 2013 Oct;133(10):2444-52 22562121 - Breast Cancer Res Treat. 2012 Aug;135(1):103-14 19268536 - Nutrition. 2009 Sep;25(9):964-72 19903865 - Am J Physiol Endocrinol Metab. 2010 Jan;298(1):E127-37 12808448 - Nat Med. 2003 Jul;9(7):964-8 16787365 - Med Chem. 2006 Mar;2(2):169-74 15653507 - Science. 2005 Jan 14;307(5707):269-73 24976155 - Acta Pharmacol Sin. 2014 Aug;35(8):1045-54 22466958 - Basic Res Cardiol. 2012 May;107(3):263 14634121 - J Immunol. 2003 Dec 1;171(11):6072-9 11994400 - J Clin Invest. 2002 May;109(9):1133-7 11967010 - Kidney Int. 2002 May;61(5):1605-16 14694152 - J Am Soc Nephrol. 2004 Jan;15(1):1-12 19428059 - Urology. 2009 Oct;74(4):938-43 19680224 - EMBO J. 2009 Sep 16;28(18):2748-62 7543024 - Cell. 1995 Jul 28;82(2):241-50 21189404 - Hypertension. 2011 Feb;57(2):314-22 10851045 - Oncogene. 2000 May 15;19(21):2468-73 24655440 - Mol Cancer. 2014;13:66 10929036 - Br J Haematol. 2000 Jun;109(4):823-8 22734110 - Nephrol Dial Transplant. 2012 Aug;27(8):3049-56 21465537 - J Cell Biochem. 2011 Aug;112(8):2138-48 20534345 - Chem Biol. 2010 May 28;17(5):471-82 23681230 - Cell Death Dis. 2013;4:e635 22357921 - Am J Physiol Renal Physiol. 2012 Jun 1;302(11):F1418-29 24151255 - Anat Rec (Hoboken). 2013 Dec;296(12):1865-73 19879325 - Mol Cell Endocrinol. 2010 Feb 5;315(1-2):188-94 20412564 - J Inflamm (Lond). 2010 Apr 22;7:19 11923478 - Mol Endocrinol. 2002 Apr;16(4):824-36 21737953 - Circ J. 2011;75(9):2151-9 12081572 - Kidney Int. 2002 Jul;62(1):137-46 15649887 - J Biol Chem. 2005 Mar 25;280(12):11528-34 22362908 - J Am Soc Nephrol. 2012 May;23(5):854-67 12846741 - Kidney Int. 2003 Aug;64(2):459-67 9468195 - Circ Res. 1998 Feb 9;82(2):244-50 23730211 - Neoplasia. 2013 Jun;15(6):631-40 19748527 - Regul Pept. 2010 Jan 8;159(1-3):110-6 23408169 - Am J Physiol Renal Physiol. 2013 Apr 15;304(8):F1054-65 21885871 - Diabetes. 2011 Nov;60(11):2975-84 22684029 - Acta Pharmacol Sin. 2012 Jul;33(7):953-63 12163453 - J Clin Invest. 2002 Aug;110(3):341-50 18782771 - J Biol Chem. 2008 Nov 7;283(45):30725-34 8628398 - Nature. 1996 Feb 15;379(6566):645-8 16408108 - Kidney Int. 2006 Jan;69(2):213-7 21098725 - FASEB J. 2011 Mar;25(3):916-27 18322023 - Am J Physiol Renal Physiol. 2008 May;294(5):F1238-48 22504904 - Acta Pharmacol Sin. 2012 May;33(5):682-90 23390536 - PLoS One. 2013;8(2):e55481 24747164 - Acta Pharmacol Sin. 2014 Jun;35(6):770-8 23904224 - Am J Physiol Renal Physiol. 2013 Oct 1;305(7):F1014-21 16285960 - Gastroenterology. 2005 Nov;129(5):1616-32 17065349 - Diabetes. 2006 Nov;55(11):3104-11 18411006 - Alcohol. 2008 Aug;42(5):397-406 23334241 - Acta Pharmacol Sin. 2013 Mar;34(3):352-9 19640900 - Am J Physiol Renal Physiol. 2009 Oct;297(4):F996-F1005 17995582 - Nephrology (Carlton). 2007 Dec;12(6):565-71 |
References_xml | – volume: 33 start-page: 682 year: 2012 end-page: 90 ident: CR22 article-title: Celecoxib induces apoptosis and cell-cycle arrest in nasopharyngeal carcinoma cell lines via inhibition of STAT3 phosphorylation publication-title: Acta Pharmacol Sin doi: 10.1038/aps.2012.18 – volume: 305 start-page: F1014 year: 2013 end-page: F1021 ident: CR3 article-title: IL-18 induces profibrotic renal tubular cell injury via STAT3 activation publication-title: Am J Physiol Renal Physiol doi: 10.1152/ajprenal.00620.2012 – volume: 307 start-page: 269 year: 2005 end-page: 73 ident: CR28 article-title: Stat3 dimerization regulated by reversible acetylation of a single lysine residue publication-title: Science doi: 10.1126/science.1105166 – volume: 302 start-page: F1418 year: 2012 end-page: F1429 ident: CR37 article-title: The transcription factor ETS-1 regulates angiotensin II-stimulated fibronectin production in mesangial cells publication-title: Am J Physiol Renal Physiol doi: 10.1152/ajprenal.00477.2011 – volume: 34 start-page: 352 year: 2013 end-page: 9 ident: CR11 article-title: Apocynin attenuates oxidative stress and cardiac fibrosis in angiotensin II-induced cardiac diastolic dysfunction in mice publication-title: Acta Pharmacol Sin doi: 10.1038/aps.2012.164 – volume: 35 start-page: 1045 year: 2014 end-page: 54 ident: CR43 article-title: STAT3 acetylation is associated with angiotesin II-induced murine renal fibrosis publication-title: Acta Pharmacol Sin doi: 10.1038/aps.2014.42 – volume: 298 start-page: E127 year: 2010 end-page: E137 ident: CR35 article-title: Transcriptional coactivator p300 regulates glucose-induced gene expression in endothelial cells publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.00432.2009 – volume: 64 start-page: 459 year: 2003 end-page: 67 ident: CR20 article-title: STAT proteins mediate angiotensin II-induced production of TIMP-1 in human proximal tubular epithelial cells publication-title: Kidney Int doi: 10.1046/j.1523-1755.2003.00133.x – volume: 379 start-page: 645 year: 1996 end-page: 8 ident: CR53 article-title: Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor publication-title: Nature doi: 10.1038/379645a0 – volume: 294 start-page: F1238 year: 2008 end-page: F1248 ident: CR8 article-title: Mesenchymal transition in kidney collecting duct epithelial cells publication-title: Am J Physiol Renal Physiol doi: 10.1152/ajprenal.00326.2007 – volume: 280 start-page: 11528 year: 2005 end-page: 34 ident: CR27 article-title: Activation of Stat3 sequence-specific DNA binding and transcription by p300/CREB-binding protein-mediated acetylation publication-title: J Biol Chem doi: 10.1074/jbc.M413930200 – volume: 12 start-page: 565 year: 2007 end-page: 71 ident: CR23 article-title: Signal transducer and activator of transcription 3 involvement in the development of renal interstitial fibrosis after unilateral ureteral obstruction publication-title: Nephrology (Carlton) doi: 10.1111/j.1440-1797.2007.00881.x – volume: 159 start-page: 110 year: 2010 end-page: 6 ident: CR18 article-title: Angiotensin II activates JAK2/STAT3 pathway and induces interleukin-6 production in cultured rat brainstem astrocytes publication-title: Regul Pept doi: 10.1016/j.regpep.2009.09.001 – volume: 23 start-page: 854 year: 2012 end-page: 67 ident: CR25 article-title: Genetic or pharmacologic blockade of EGFR inhibits renal fibrosis publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2011050493 – volume: 57 start-page: 314 year: 2011 end-page: 22 ident: CR10 article-title: Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2 publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.110.164244 – volume: 42 start-page: 397 year: 2008 end-page: 406 ident: CR17 article-title: Ethanol inhibition of angiotensin II-stimulated Tyr705 and Ser727 STAT3 phosphorylation in cultured rat hepatocytes: relevance to activation of p42/44 mitogen-activated protein kinase publication-title: Alcohol doi: 10.1016/j.alcohol.2008.02.004 – volume: 28 start-page: 2748 year: 2009 end-page: 62 ident: CR30 article-title: SENP3 is responsible for HIF-1 transactivation under mild oxidative stress via p300 de-SUMOylation publication-title: EMBO J doi: 10.1038/emboj.2009.210 – volume: 82 start-page: 241 year: 1995 end-page: 50 ident: CR26 article-title: Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation publication-title: Cell doi: 10.1016/0092-8674(95)90311-9 – volume: 25 start-page: 916 year: 2011 end-page: 27 ident: CR38 article-title: STAT3-dependent effects of IL-22 in human keratinocytes are counterregulated by sirtuin 1 through a direct inhibition of STAT3 acetylation publication-title: FASEB J doi: 10.1096/fj.10-172288 – volume: 69 start-page: 213 year: 2006 end-page: 7 ident: CR2 article-title: Renal fibrosis: new insights into the pathogenesis and therapeutics publication-title: Kidney Int doi: 10.1038/sj.ki.5000054 – volume: 17 start-page: 471 year: 2010 end-page: 82 ident: CR50 article-title: Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor publication-title: Chem Biol doi: 10.1016/j.chembiol.2010.03.006 – volume: 315 start-page: 188 year: 2010 end-page: 94 ident: CR44 article-title: Angiotensin II type 2 receptor mediated angiotensin II and high glucose induced decrease in renal prorenin/renin receptor expression publication-title: Mol Cell Endocrinol doi: 10.1016/j.mce.2009.10.008 – volume: 171 start-page: 6072 year: 2003 end-page: 9 ident: CR47 article-title: Curcumin suppresses Janus kinase-STAT inflammatory signaling through activation of Src homology 2 domain-containing tyrosine phosphatase 2 in brain microglia publication-title: J Immunol doi: 10.4049/jimmunol.171.11.6072 – volume: 60 start-page: 2975 year: 2011 end-page: 84 ident: CR36 article-title: miR-146a-Mediated extracellular matrix protein production in chronic diabetes complications publication-title: Diabetes doi: 10.2337/db11-0478 – volume: 13 start-page: 66 year: 2014 ident: CR41 article-title: Inhibition of STAT3 dimerization and acetylation by garcinol suppresses the growth of human hepatocellular carcinoma and publication-title: Mol Cancer doi: 10.1186/1476-4598-13-66 – volume: 135 start-page: 103 year: 2012 end-page: 14 ident: CR39 article-title: Auto-acetylation stabilizes p300 in cardiac myocytes during acute oxidative stress, promoting STAT3 accumulation and cell survival publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-012-2069-6 – volume: 129 start-page: 1616 year: 2005 end-page: 32 ident: CR57 article-title: STAT3 NH -terminal acetylation is activated by the hepatic acute-phase response and required for IL-6 induction of angiotensinogen publication-title: Gastroenterology doi: 10.1053/j.gastro.2005.07.055 – volume: 109 start-page: 823 year: 2000 end-page: 8 ident: CR54 article-title: JAK2 tyrosine kinase inhibitor tyrphostin AG490 downregulates the mitogen-activated protein kinase (MAPK) and signal transducer and activator of transcription (STAT) pathways and induces apoptosis in myeloma cells publication-title: Br J Haematol doi: 10.1046/j.1365-2141.2000.02127.x – volume: 61 start-page: 1605 year: 2002 end-page: 16 ident: CR19 article-title: Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose publication-title: Kidney Int doi: 10.1046/j.1523-1755.2002.00311.x – volume: 109 start-page: 1133 year: 2002 end-page: 7 ident: CR15 article-title: Series introduction. JAK-STAT signaling in human disease publication-title: J Clin Invest doi: 10.1172/JCI0215644 – volume: 35 start-page: 770 year: 2014 end-page: 8 ident: CR56 article-title: Cyclovirobuxinum D suppresses lipopolysaccharide-induced inflammatory responses in murine macrophages by blocking JAK-STAT signaling pathway publication-title: Acta Pharmacol Sin doi: 10.1038/aps.2014.16 – volume: 55 start-page: 3104 year: 2006 end-page: 11 ident: CR33 article-title: Diabetes-induced extracellular matrix protein expression is mediated by transcription coactivator p300 publication-title: Diabetes doi: 10.2337/db06-0519 – volume: 82 start-page: 244 year: 1998 end-page: 50 ident: CR16 article-title: Biphasic activation of the JAK/STAT pathway by angiotensin II in rat cardiomyocytes publication-title: Circ Res doi: 10.1161/01.RES.82.2.244 – volume: 304 start-page: F1054 year: 2013 end-page: F1065 ident: CR9 article-title: Proximal tubule-specific overexpression of netrin-1 suppresses acute kidney injury-induced interstitial fibrosis and glomerulosclerosis through suppression of IL-6/STAT3 signaling publication-title: Am J Physiol Renal Physiol doi: 10.1152/ajprenal.00650.2012 – volume: 297 start-page: F996 year: 2009 end-page: F1005 ident: CR24 article-title: Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy publication-title: Am J Physiol Renal Physiol doi: 10.1152/ajprenal.00282.2009 – volume: 133 start-page: 2444 year: 2013 end-page: 52 ident: CR52 article-title: Selective inhibition of p300 HAT blocks cell cycle progression, induces cellular senescence, and inhibits the DNA damage response in melanoma cells publication-title: J Invest Dermatol doi: 10.1038/jid.2013.187 – volume: 15 start-page: 1 year: 2004 end-page: 12 ident: CR5 article-title: Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention publication-title: J Am Soc Nephrol doi: 10.1097/01.ASN.0000106015.29070.E7 – volume: 16 start-page: 824 year: 2002 end-page: 36 ident: CR29 article-title: Angiotensinogen gene expression is dependent on signal transducer and activator of transcription 3-mediated p300/cAMP response element binding protein-binding protein coactivator recruitment and histone acetyltransferase activity publication-title: Mol Endocrinol doi: 10.1210/mend.16.4.0811 – volume: 15 start-page: 631 year: 2013 end-page: 40 ident: CR49 article-title: Curcumin triggers p16-dependent senescence in active breast cancer-associated fibroblasts and suppresses their paracrine procarcinogenic effects publication-title: Neoplasia doi: 10.1593/neo.13478 – volume: 112 start-page: 2138 year: 2011 end-page: 48 ident: CR42 article-title: Histone deacetylase 1/2 mediates proliferation of renal interstitial fibroblasts and expression of cell cycle proteins publication-title: J Cell Biochem doi: 10.1002/jcb.23135 – volume: 110 start-page: 341 year: 2002 end-page: 50 ident: CR4 article-title: Evidence that fibroblasts derive from epithelium during tissue fibrosis publication-title: J Clin Invest doi: 10.1172/JCI0215518 – volume: 8 start-page: e 55481 year: 2013 ident: CR51 article-title: A histone acetyltransferase p300 inhibitor C646 induces cell cycle arrest and apoptosis selectively in AML1-ETO-positive AML cells publication-title: PLoS One doi: 10.1371/journal.pone.0055481 – volume: 7 start-page: 19 year: 2010 ident: CR13 article-title: Role of inflammation in tubulo-interstitial damage associated to obstructive nephropathy publication-title: J Inflamm (Lond) doi: 10.1186/1476-9255-7-19 – volume: 19 start-page: 2468 year: 2000 end-page: 73 ident: CR21 article-title: The role of STATs in transcriptional control and their impact on cellular function publication-title: Oncogene doi: 10.1038/sj.onc.1203476 – volume: 27 start-page: 3049 year: 2012 end-page: 56 ident: CR14 article-title: The pathogenic role of the renal proximal tubular cell in diabetic nephropathy publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/gfs260 – volume: 75 start-page: 2151 year: 2011 end-page: 9 ident: CR46 article-title: A natural p300-specific histone acetyltransferase inhibitor, curcumin, in addition to angiotensin-converting enzyme inhibitor, exerts beneficial effects on left ventricular systolic function after myocardial infarction in rats publication-title: Circ J doi: 10.1253/circj.CJ-10-1072 – volume: 33 start-page: 953 year: 2012 end-page: 63 ident: CR31 article-title: The biphasic redox sensing of SENP3 accounts for the HIF-1 transcriptional activity shift by oxidative stress publication-title: Acta Pharmacol Sin doi: 10.1038/aps.2012.40 – volume: 107 start-page: 263 year: 2012 ident: CR48 article-title: The effects of curcumin post-treatment against myocardial ischemia and reperfusion by activation of the JAK2/STAT3 signaling pathway publication-title: Basic Res Cardiol doi: 10.1007/s00395-012-0263-7 – volume: 296 start-page: 1865 year: 2013 end-page: 73 ident: CR55 article-title: Involvement of nuclear JAK2 signaling in AG490-induced apoptosis of gastric cancer cells publication-title: Anat Rec (Hoboken) doi: 10.1002/ar.22820 – volume: 62 start-page: 137 year: 2002 end-page: 46 ident: CR6 article-title: Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies publication-title: Kidney Int doi: 10.1046/j.1523-1755.2002.00430.x – volume: 74 start-page: 938 year: 2009 end-page: 43 ident: CR12 article-title: Renal damage inhibited in mice lacking angiotensinogen gene subjected to unilateral ureteral obstruction publication-title: Urology doi: 10.1016/j.urology.2009.02.059 – volume: 2 start-page: 169 year: 2006 end-page: 74 ident: CR45 article-title: Curcumin is an inhibitor of p300 histone acetylatransferase publication-title: Med Chem doi: 10.2174/157340606776056133 – volume: 9 start-page: 964 year: 2003 end-page: 8 ident: CR7 article-title: BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury publication-title: Nat Med doi: 10.1038/nm888 – volume: 4 start-page: e635 year: 2013 ident: CR40 article-title: SIRT1 activation enhances HDAC inhibition-mediated upregulation of GADD45G by repressing the binding of NF-kappaB/STAT3 complex to its promoter in malignant lymphoid cells publication-title: Cell Death Dis doi: 10.1038/cddis.2013.159 – volume: 283 start-page: 30725 year: 2008 end-page: 34 ident: CR32 article-title: The STAT3 NH -terminal domain stabilizes enhanceosome assembly by interacting with the p300 bromodomain publication-title: J Biol Chem doi: 10.1074/jbc.M805941200 – volume: 12 start-page: 353 year: 2005 end-page: 65 ident: CR1 article-title: The STAT3 NH -terminal domain stabilizes enhanceosome assembly by interacting with the p300 bromodomain publication-title: Adv Chronic Kidney Dis doi: 10.1053/j.ackd.2005.07.011 – volume: 25 start-page: 964 year: 2009 end-page: 72 ident: CR34 article-title: Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor-kappaB publication-title: Nutrition doi: 10.1016/j.nut.2008.12.007 – volume: 13 start-page: 66 year: 2014 ident: BFaps201454_CR41 publication-title: Mol Cancer doi: 10.1186/1476-4598-13-66 – volume: 8 start-page: e 55481 year: 2013 ident: BFaps201454_CR51 publication-title: PLoS One doi: 10.1371/journal.pone.0055481 – volume: 112 start-page: 2138 year: 2011 ident: BFaps201454_CR42 publication-title: J Cell Biochem doi: 10.1002/jcb.23135 – volume: 315 start-page: 188 year: 2010 ident: BFaps201454_CR44 publication-title: Mol Cell Endocrinol doi: 10.1016/j.mce.2009.10.008 – volume: 57 start-page: 314 year: 2011 ident: BFaps201454_CR10 publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.110.164244 – volume: 16 start-page: 824 year: 2002 ident: BFaps201454_CR29 publication-title: Mol Endocrinol doi: 10.1210/mend.16.4.0811 – volume: 109 start-page: 823 year: 2000 ident: BFaps201454_CR54 publication-title: Br J Haematol doi: 10.1046/j.1365-2141.2000.02127.x – volume: 15 start-page: 631 year: 2013 ident: BFaps201454_CR49 publication-title: Neoplasia doi: 10.1593/neo.13478 – volume: 12 start-page: 353 year: 2005 ident: BFaps201454_CR1 publication-title: Adv Chronic Kidney Dis doi: 10.1053/j.ackd.2005.07.011 – volume: 379 start-page: 645 year: 1996 ident: BFaps201454_CR53 publication-title: Nature doi: 10.1038/379645a0 – volume: 133 start-page: 2444 year: 2013 ident: BFaps201454_CR52 publication-title: J Invest Dermatol doi: 10.1038/jid.2013.187 – volume: 82 start-page: 241 year: 1995 ident: BFaps201454_CR26 publication-title: Cell doi: 10.1016/0092-8674(95)90311-9 – volume: 4 start-page: e635 year: 2013 ident: BFaps201454_CR40 publication-title: Cell Death Dis doi: 10.1038/cddis.2013.159 – volume: 61 start-page: 1605 year: 2002 ident: BFaps201454_CR19 publication-title: Kidney Int doi: 10.1046/j.1523-1755.2002.00311.x – volume: 296 start-page: 1865 year: 2013 ident: BFaps201454_CR55 publication-title: Anat Rec (Hoboken) doi: 10.1002/ar.22820 – volume: 42 start-page: 397 year: 2008 ident: BFaps201454_CR17 publication-title: Alcohol doi: 10.1016/j.alcohol.2008.02.004 – volume: 64 start-page: 459 year: 2003 ident: BFaps201454_CR20 publication-title: Kidney Int doi: 10.1046/j.1523-1755.2003.00133.x – volume: 27 start-page: 3049 year: 2012 ident: BFaps201454_CR14 publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/gfs260 – volume: 33 start-page: 682 year: 2012 ident: BFaps201454_CR22 publication-title: Acta Pharmacol Sin doi: 10.1038/aps.2012.18 – volume: 25 start-page: 964 year: 2009 ident: BFaps201454_CR34 publication-title: Nutrition doi: 10.1016/j.nut.2008.12.007 – volume: 2 start-page: 169 year: 2006 ident: BFaps201454_CR45 publication-title: Med Chem doi: 10.2174/157340606776056133 – volume: 35 start-page: 770 year: 2014 ident: BFaps201454_CR56 publication-title: Acta Pharmacol Sin doi: 10.1038/aps.2014.16 – volume: 7 start-page: 19 year: 2010 ident: BFaps201454_CR13 publication-title: J Inflamm (Lond) doi: 10.1186/1476-9255-7-19 – volume: 110 start-page: 341 year: 2002 ident: BFaps201454_CR4 publication-title: J Clin Invest doi: 10.1172/JCI0215518 – volume: 17 start-page: 471 year: 2010 ident: BFaps201454_CR50 publication-title: Chem Biol doi: 10.1016/j.chembiol.2010.03.006 – volume: 55 start-page: 3104 year: 2006 ident: BFaps201454_CR33 publication-title: Diabetes doi: 10.2337/db06-0519 – volume: 129 start-page: 1616 year: 2005 ident: BFaps201454_CR57 publication-title: Gastroenterology doi: 10.1053/j.gastro.2005.07.055 – volume: 69 start-page: 213 year: 2006 ident: BFaps201454_CR2 publication-title: Kidney Int doi: 10.1038/sj.ki.5000054 – volume: 75 start-page: 2151 year: 2011 ident: BFaps201454_CR46 publication-title: Circ J doi: 10.1253/circj.CJ-10-1072 – volume: 304 start-page: F1054 year: 2013 ident: BFaps201454_CR9 publication-title: Am J Physiol Renal Physiol doi: 10.1152/ajprenal.00650.2012 – volume: 82 start-page: 244 year: 1998 ident: BFaps201454_CR16 publication-title: Circ Res doi: 10.1161/01.RES.82.2.244 – volume: 307 start-page: 269 year: 2005 ident: BFaps201454_CR28 publication-title: Science doi: 10.1126/science.1105166 – volume: 305 start-page: F1014 year: 2013 ident: BFaps201454_CR3 publication-title: Am J Physiol Renal Physiol doi: 10.1152/ajprenal.00620.2012 – volume: 107 start-page: 263 year: 2012 ident: BFaps201454_CR48 publication-title: Basic Res Cardiol doi: 10.1007/s00395-012-0263-7 – volume: 302 start-page: F1418 year: 2012 ident: BFaps201454_CR37 publication-title: Am J Physiol Renal Physiol doi: 10.1152/ajprenal.00477.2011 – volume: 35 start-page: 1045 year: 2014 ident: BFaps201454_CR43 publication-title: Acta Pharmacol Sin doi: 10.1038/aps.2014.42 – volume: 74 start-page: 938 year: 2009 ident: BFaps201454_CR12 publication-title: Urology doi: 10.1016/j.urology.2009.02.059 – volume: 25 start-page: 916 year: 2011 ident: BFaps201454_CR38 publication-title: FASEB J doi: 10.1096/fj.10-172288 – volume: 280 start-page: 11528 year: 2005 ident: BFaps201454_CR27 publication-title: J Biol Chem doi: 10.1074/jbc.M413930200 – volume: 298 start-page: E127 year: 2010 ident: BFaps201454_CR35 publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.00432.2009 – volume: 297 start-page: F996 year: 2009 ident: BFaps201454_CR24 publication-title: Am J Physiol Renal Physiol doi: 10.1152/ajprenal.00282.2009 – volume: 12 start-page: 565 year: 2007 ident: BFaps201454_CR23 publication-title: Nephrology (Carlton) doi: 10.1111/j.1440-1797.2007.00881.x – volume: 15 start-page: 1 year: 2004 ident: BFaps201454_CR5 publication-title: J Am Soc Nephrol doi: 10.1097/01.ASN.0000106015.29070.E7 – volume: 109 start-page: 1133 year: 2002 ident: BFaps201454_CR15 publication-title: J Clin Invest doi: 10.1172/JCI0215644 – volume: 171 start-page: 6072 year: 2003 ident: BFaps201454_CR47 publication-title: J Immunol doi: 10.4049/jimmunol.171.11.6072 – volume: 294 start-page: F1238 year: 2008 ident: BFaps201454_CR8 publication-title: Am J Physiol Renal Physiol doi: 10.1152/ajprenal.00326.2007 – volume: 23 start-page: 854 year: 2012 ident: BFaps201454_CR25 publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2011050493 – volume: 9 start-page: 964 year: 2003 ident: BFaps201454_CR7 publication-title: Nat Med doi: 10.1038/nm888 – volume: 283 start-page: 30725 year: 2008 ident: BFaps201454_CR32 publication-title: J Biol Chem doi: 10.1074/jbc.M805941200 – volume: 62 start-page: 137 year: 2002 ident: BFaps201454_CR6 publication-title: Kidney Int doi: 10.1046/j.1523-1755.2002.00430.x – volume: 159 start-page: 110 year: 2010 ident: BFaps201454_CR18 publication-title: Regul Pept doi: 10.1016/j.regpep.2009.09.001 – volume: 33 start-page: 953 year: 2012 ident: BFaps201454_CR31 publication-title: Acta Pharmacol Sin doi: 10.1038/aps.2012.40 – volume: 28 start-page: 2748 year: 2009 ident: BFaps201454_CR30 publication-title: EMBO J doi: 10.1038/emboj.2009.210 – volume: 135 start-page: 103 year: 2012 ident: BFaps201454_CR39 publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-012-2069-6 – volume: 19 start-page: 2468 year: 2000 ident: BFaps201454_CR21 publication-title: Oncogene doi: 10.1038/sj.onc.1203476 – volume: 60 start-page: 2975 year: 2011 ident: BFaps201454_CR36 publication-title: Diabetes doi: 10.2337/db11-0478 – volume: 34 start-page: 352 year: 2013 ident: BFaps201454_CR11 publication-title: Acta Pharmacol Sin doi: 10.1038/aps.2012.164 – reference: 14634121 - J Immunol. 2003 Dec 1;171(11):6072-9 – reference: 17065349 - Diabetes. 2006 Nov;55(11):3104-11 – reference: 19640900 - Am J Physiol Renal Physiol. 2009 Oct;297(4):F996-F1005 – reference: 18782771 - J Biol Chem. 2008 Nov 7;283(45):30725-34 – reference: 11994400 - J Clin Invest. 2002 May;109(9):1133-7 – reference: 21189404 - Hypertension. 2011 Feb;57(2):314-22 – reference: 16408108 - Kidney Int. 2006 Jan;69(2):213-7 – reference: 24976155 - Acta Pharmacol Sin. 2014 Aug;35(8):1045-54 – reference: 18322023 - Am J Physiol Renal Physiol. 2008 May;294(5):F1238-48 – reference: 7543024 - Cell. 1995 Jul 28;82(2):241-50 – reference: 10851045 - Oncogene. 2000 May 15;19(21):2468-73 – reference: 21737953 - Circ J. 2011;75(9):2151-9 – reference: 23730211 - Neoplasia. 2013 Jun;15(6):631-40 – reference: 22734110 - Nephrol Dial Transplant. 2012 Aug;27(8):3049-56 – reference: 11967010 - Kidney Int. 2002 May;61(5):1605-16 – reference: 16787365 - Med Chem. 2006 Mar;2(2):169-74 – reference: 20534345 - Chem Biol. 2010 May 28;17(5):471-82 – reference: 14694152 - J Am Soc Nephrol. 2004 Jan;15(1):1-12 – reference: 21885871 - Diabetes. 2011 Nov;60(11):2975-84 – reference: 11923478 - Mol Endocrinol. 2002 Apr;16(4):824-36 – reference: 24655440 - Mol Cancer. 2014;13:66 – reference: 23681230 - Cell Death Dis. 2013;4:e635 – reference: 23334241 - Acta Pharmacol Sin. 2013 Mar;34(3):352-9 – reference: 21098725 - FASEB J. 2011 Mar;25(3):916-27 – reference: 15653507 - Science. 2005 Jan 14;307(5707):269-73 – reference: 9468195 - Circ Res. 1998 Feb 9;82(2):244-50 – reference: 23390536 - PLoS One. 2013;8(2):e55481 – reference: 19879325 - Mol Cell Endocrinol. 2010 Feb 5;315(1-2):188-94 – reference: 19680224 - EMBO J. 2009 Sep 16;28(18):2748-62 – reference: 19748527 - Regul Pept. 2010 Jan 8;159(1-3):110-6 – reference: 22562121 - Breast Cancer Res Treat. 2012 Aug;135(1):103-14 – reference: 21465537 - J Cell Biochem. 2011 Aug;112(8):2138-48 – reference: 15649887 - J Biol Chem. 2005 Mar 25;280(12):11528-34 – reference: 12081572 - Kidney Int. 2002 Jul;62(1):137-46 – reference: 12808448 - Nat Med. 2003 Jul;9(7):964-8 – reference: 19903865 - Am J Physiol Endocrinol Metab. 2010 Jan;298(1):E127-37 – reference: 12163453 - J Clin Invest. 2002 Aug;110(3):341-50 – reference: 22357921 - Am J Physiol Renal Physiol. 2012 Jun 1;302(11):F1418-29 – reference: 12846741 - Kidney Int. 2003 Aug;64(2):459-67 – reference: 19268536 - Nutrition. 2009 Sep;25(9):964-72 – reference: 10929036 - Br J Haematol. 2000 Jun;109(4):823-8 – reference: 8628398 - Nature. 1996 Feb 15;379(6566):645-8 – reference: 17995582 - Nephrology (Carlton). 2007 Dec;12(6):565-71 – reference: 24747164 - Acta Pharmacol Sin. 2014 Jun;35(6):770-8 – reference: 23904224 - Am J Physiol Renal Physiol. 2013 Oct 1;305(7):F1014-21 – reference: 18411006 - Alcohol. 2008 Aug;42(5):397-406 – reference: 23698071 - J Invest Dermatol. 2013 Oct;133(10):2444-52 – reference: 22362908 - J Am Soc Nephrol. 2012 May;23(5):854-67 – reference: 22504904 - Acta Pharmacol Sin. 2012 May;33(5):682-90 – reference: 22684029 - Acta Pharmacol Sin. 2012 Jul;33(7):953-63 – reference: 22466958 - Basic Res Cardiol. 2012 May;107(3):263 – reference: 23408169 - Am J Physiol Renal Physiol. 2013 Apr 15;304(8):F1054-65 – reference: 16285960 - Gastroenterology. 2005 Nov;129(5):1616-32 – reference: 19428059 - Urology. 2009 Oct;74(4):938-43 – reference: 24151255 - Anat Rec (Hoboken). 2013 Dec;296(12):1865-73 – reference: 20412564 - J Inflamm (Lond). 2010 Apr 22;7:19 |
SSID | ssj0032319 |
Score | 2.2525697 |
Snippet | Aim: To explore the role of signal transducer and activator of transcription 3 (STAT3) signaling pathway, especially STAT3 acetylation, in angiotensin II (Ang... Aim: To explore the signal transducer and activator of transcription 3 (STAT3) signaling pathway, especially STAT3 acetylation, in angiotensin II (Ang... To explore the signal transducer and activator of transcription 3 (STAT3) signaling pathway, especially STAT3 acetylation, in angiotensin II (Ang II)-induced... |
SourceID | pubmedcentral proquest pubmed crossref springer chongqing |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1157 |
SubjectTerms | Acetylation - drug effects Angiotensin II - pharmacology Animals Biomedical and Life Sciences Biomedicine Cell Line E1A-Associated p300 Protein - metabolism Epithelial Cells - drug effects Epithelial Cells - metabolism Fibrosis - chemically induced Fibrosis - metabolism Immunology Internal Medicine Kidney Tubules - drug effects Kidney Tubules - metabolism Medical Microbiology Original original-article P300 Pharmacology/Toxicology Rats STAT3 STAT3 Transcription Factor - metabolism Vaccine 乙酰化 依赖性 纤维化 肾小管上皮细胞 血管紧张素II 诱导作用 |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB5BOcAFlXdoQUYqPaCGJnGcOCdUIaoWCbQSW2lvkePY7UqVs91kD3vkn3cmr2VZxNmTxMmM7W8yM98AHInAhkJa44dKKD-2QeArUSS-4aUNbRkVRUYFzj9-JhdX8feZmPU_3Oo-rXLYE9uNuqw0_SM_pfAZ4QMeflnc-dQ1iqKrfQuNh_CIqMsopSudjQ4XR-xC8DdMUvKTJO_r8wIuT9WCuLrD-DP1AXiMO427vsOzYvt02oGcu5mTf4VP21PpfB-e9nCSnXX6fwYPjHsOx5OOj3p9wqab8qr6hB2zyYapev0Cfk84frWhD27Dfk3PppwpbZp1lyLH5jVzhioJ1HLNEN8y5a7nVZv17tjlpY8ePdpGyfAdfIued4UPYssu79bUDIWWhibYrArKd2VmQTUgt2j0jEIG9Uu4Ov82_Xrh9z0ZfC141uCWHRCXrUiVslIrREM24crYTBlFVGi8lDzJuEo0-kWlljiKOo-UxD01i9AjfgV7rnLmDTC8skQNpYpnNtahUIh9TKSjEi_nUmsPDka95IuOeyMngBRLBCEefBo0leuezpy6atzmbVidyxxVnJOKcxF7cDQKD3f6p9jhoPK8X8p1vjE8Dz6Mw7gI6TMpZ6oVySSEVdH38-B1ZyHjcyKCwHjueJBu2c4oQATf2yNuftMSfRPYE1HqwcfByv6Y1u703_5_-gfwhAS7BLlD2GuWK_MOEVVTvG-XzT1w7SI9 priority: 102 providerName: ProQuest |
Title | P300-dependent STAT3 acetylation is necessary for angiotensin II-induced pro-fibrotic responses in renal tubular epithelial cells |
URI | http://lib.cqvip.com/qk/95561A/201409/663548061.html https://link.springer.com/article/10.1038/aps.2014.54 https://www.ncbi.nlm.nih.gov/pubmed/25088002 https://www.proquest.com/docview/1559008531 https://www.proquest.com/docview/1560095875 https://pubmed.ncbi.nlm.nih.gov/PMC4155527 |
Volume | 35 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1La9tAEB7yuPRS-q6S1GwhzaFEqaXV6nEoxS4xSSHGtDb4JtarVWIwkiPJUB37zzujV-o4h5502FntamdW8w3zAjgV_dgSfqxNSwppOnG_b0qxcE3No9iKI3uxCCjB-WbsXs2cH3Mx34O2GWdzgPmTph31k5plq4vf9-U3vPBf65Rx_4tcU91ty7kQzj4cokry6IbeOJ07gSOICerMSOrdKpwmUe_RZCqvcJcmt_eoNLbV1A723A2hfORHrdTT6AU8b3AlG9SC8BL2dPIKziZ1YerynE0f8qzyc3bGJg8lq8vX8GfC8fjahrgF-zUdTDmTShdlHSvHljlLNKUUyKxkCHSZTG6XaRX-nrDraxNNexSSiOE3mDGa4CkuxLI6AFfnDIkyTRssNgsKfGV6TckgK5R-Rr6D_A3MRpfT71dm05zBVIIHBf67-1TUVnhSxr6SCItil0sdB1JLqonGI5-7AZeuQgMpUj6OIvNt6ePPNbDRNH4LB0ma6PfAcGaEHPIkD2JHWUIiCNK2siOczn2lDDju-BKu6yIcISElx0c0YsDnllOhauqaU3uNVVj517kfIotDYnEoHANOO-L2TU-SnbQsD1uRDMmBSwiV45Ifu2G8jXRMMtHphmhcAq1oBBrwrpaQbh2bsDAqIAO8LdnpCKjS9_ZIsryrKn4T6hO2Z8CnVsr-2dbu9o_-Y3_H8Iyo63C5Ezgoso3-gPiqWPRg35t7PTgcjIbDMT6Hl-PJz151o_4Cn_0qfQ |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6V9FAuiDemBRap7QHV1Pb6eUCoQKuEtlEErtSbWa_XJVJlp7Ej5CN_iN_IjF8hBHHreWftTWZ25hvPC2DXMVLT8VOlm8IRup0ahi6c2NUVT1IzTaw4DqjA-XzsDi_sz5fO5Qb86mphKK2y04m1ok5ySd_IDyl8RviAm-9nNzpNjaLoajdCoxGLU1X9QJeteDf6hPzds6yT4_DjUG-nCujS4UGJSsegbqyOJ0TqS4H2PHW5UGkglKBmXjzxuRtw4UpE9on0cRVPbQkftUJgoU-Hz70DmzZHV2YAmx-Ox5Mvne7H3fUoEdP1yDPzeVsRaHD_UMyoO7hpv6XJA1uo27KrG7ROq_ZwDeSu52r-FbCt7eDJfbjXAlh21EjcA9hQ2UPYnzQdsKsDFi4LuooDts8my97Y1SP4OeHIp27ybsm-hkchZ0KqsmqS8ti0YJmi2gUxrxgiaiayq2le59lnbDTSp1mC0pgw_A16ir5-ji9i8ybTVxUMieaKDlguYsqwZWpGVSfXeM0YBSmKx3BxK_x6AoMsz9QzYLgzQQ55ggepLU1HINpSlrQS3M59KTXY7vkSzZpuHxFBMttH2KPBm45TkWwbqNMcj-uoDuRzP0IWR8TiyLE12O2Juyf9k2ynY3nUKo8iWoq6Bq_7Zbz29DeJTOULonEJHaO3qcHTRkL691gEutHSaeCtyE5PQC3FV1ey6fe6tTjBS8fyNNjrpOyPY60f__n_j_8Ktobh-Vl0NhqfbsNd2tSk5-3AoJwv1AvEc2X8sr1EDL7d9r39DbvjXzo |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VIgEXxBvTAovU9oBqEnu9fhwQqihRQ6GKRCrl5m7WuyVSZaexI-Qjf4tfx4xfIQRx63ln7XXmsd9kXgB7om8cERptO1JI2zP9vi3F1Lc1T4xjEnc6jajA-euZf3LufZ6IyRb8amthKK2ytYmVoU4yRf-R9yh8RviAOz3TpEWMjgcf5tc2TZCiSGs7TqMWkVNd_kD3LX8_PEZe77vu4NP444ndTBiwleBRgQaoT51ZRSClCZXEu934XGoTSS2psRdPQu5HXPoKUX6iQlzFL3BliBYictG_w-fegtsBFw7pWDDpnD3cWw0VcfyAfLSQN7WBfR725Jz6hDveO5pBcBetXHp5jffU-s24AXc3szb_Ct1WN-LgAdxvoCw7qmXvIWzp9BEcjOpe2OUhG69Ku_JDdsBGqy7Z5WP4OeLIsXYGb8G-jY_GnEmli7JOz2OznKWaqhjkomSIrZlML2dZlXGfsuHQnqUJymXC8Btsg15_hi9iizrnV-cMiRaaDlgsp5Rry_Sc6k-uUOEYhSvyJ3B-I9x6CttplurnwHBnghwKJI-MpxwhEXdpV7kJbuehUhbsdHyJ53Xfj5jAmRciALLgbcupWDWt1Gmix1VchfR5GCOLY2JxLDwL9jri9kn_JNttWR43ZiSPV0JvwZtuGQ0A_Uwy1dmSaHzCyeh3WvCslpDuPS7Bb7zzLAjWZKcjoObi6yvp7HvVZJyApnADC_ZbKfvjWJvHf_H_47-GO6it8Zfh2ekO3KM9dZ7eLmwXi6V-icCumL6qNIjBxU2r7G8YxWIK |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=P300-dependent+STAT3+acetylation+is+necessary+for+angiotensin+II-induced+pro-fibrotic+responses+in+renal+tubular+epithelial+cells&rft.jtitle=Acta+pharmacologica+Sinica&rft.au=Ni%2C+Jun&rft.au=Shen%2C+Yang&rft.au=Wang%2C+Zhen&rft.au=Shao%2C+De-cui&rft.date=2014-09-01&rft.issn=1745-7254&rft.eissn=1745-7254&rft.volume=35&rft.issue=9&rft.spage=1157&rft_id=info:doi/10.1038%2Faps.2014.54&rft.externalDBID=NO_FULL_TEXT |
thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F95561A%2F95561A.jpg |